New York State Teachers Retirement System (NYSTRS)’s Sarepta Therapeutics SRPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.81M Buy
100,515
+3,417
+4% +$64.6K ﹤0.01% 1131
2026
Q1
$2.11M Sell
97,098
-3,517
-3% -$68.1K ﹤0.01% 1043
2025
Q4
$2.17M Buy
100,615
+18,200
+22% +$384K ﹤0.01% 1085
2025
Q3
$1.59M Buy
82,415
+5,944
+8% +$106K ﹤0.01% 1186
2025
Q2
$1.31M Sell
76,471
-2,890
-4% -$123K ﹤0.01% 1223
2025
Q1
$5.07M Buy
79,361
+2,512
+3% +$264K 0.01% 762
2024
Q4
$9.34M Sell
76,849
-1,326
-2% -$163K 0.02% 560
2024
Q3
$9.76M Buy
78,175
+1,904
+2% +$263K 0.02% 559
2024
Q2
$12.1M Buy
+76,271
New +$9.8M 0.03% 479

Other funds holding SRPT

New York State Teachers Retirement System (NYSTRS)'s SRPT Position: Q2 2026 in Review

New York State Teachers Retirement System (NYSTRS) increased its Sarepta Therapeutics (SRPT) stake by 3.5% in Q2 2026, buying an estimated $64.6K and bringing the position to 100,515 shares worth $1.81M. The position accounts for ﹤0.01% of the portfolio, ranked #1131.

New York State Teachers Retirement System (NYSTRS) first reported a position in SRPT in Q2 2024 and has held it in 9 quarters since. The position peaked at $12.1M in Q2 2024. 323 funds tracked by Wall St. Rank hold SRPT as of Q2 2026.

  • New York State Teachers Retirement System (NYSTRS) held 100,515 shares of Sarepta Therapeutics worth $1.81M as of Q2 2026.
  • New York State Teachers Retirement System (NYSTRS) bought 3,417 Sarepta Therapeutics shares in Q2 2026, an estimated $64.6K.
  • Sarepta Therapeutics made up ﹤0.01% of New York State Teachers Retirement System (NYSTRS)'s portfolio in Q2 2026, its #1131 holding.
  • New York State Teachers Retirement System (NYSTRS) first reported a position in Sarepta Therapeutics in Q2 2024 and has held it in 9 quarters since.
  • New York State Teachers Retirement System (NYSTRS)'s Sarepta Therapeutics position peaked at $12.1M in Q2 2024.
  • 323 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2026.

Based on New York State Teachers Retirement System (NYSTRS)'s 13F filing for Q2 2026, filed 23 Jul 2026.